Scarica l'app Stockscreener
67.25
0.51%
0.34
Dopo l'orario di chiusura:
67.25
Precedente Chiudi:
$66.91
Aprire:
$67.1
Volume 24 ore:
2.65M
Relative Volume:
1.34
Capitalizzazione di mercato:
$13.15B
Reddito:
$579.96M
Utile/perdita netta:
$-729.89M
Rapporto P/E:
-17.95
EPS:
-3.7459
Flusso di cassa netto:
$-452.02M
1 W Prestazione:
+2.56%
1M Prestazione:
-12.09%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$66.23
$68.68
Intervallo di 1 settimana:
$64.36
$68.68
Portata 52W:
$64.36
$89.49
Bio Rad Laboratories Inc Stock (BBIO) Company Profile
Nome
Bio Rad Laboratories Inc
Settore
Industria
Telefono
(650) 391-9740
Indirizzo
3160 PORTER DR., PALO ALTO
Compare BBIO vs ABT, MDT, SYK, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BBIO
Bio Rad Laboratories Inc
|
67.25 | 12.82B | 579.96M | -729.89M | -452.02M | -3.7459 |
ABT
Abbott Laboratories
|
97.50 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
86.38 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
275.43 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
42.60 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.15 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Bio Rad Laboratories Inc Borsa (BBIO) Ultime notizie
Bio-Rad Laboratories Drops 5.2% Amid Sector-Wide Selling - AlphaStreet
Bio-Rad Laboratories, Inc. (BIO) Stock Forecasts - Yahoo Finance
Why Bio Rad Laboratories (BIO) Is Back In The Spotlight - Yahoo Finance
Avoiding Lag: Real-Time Signals in (BIO) Movement - Stock Traders Daily
Bio-Rad Laboratories, Inc. Class A Revenue Breakdown – HAN:BUWA - TradingView
Bio-Rad Laboratories, Inc. (BIO) stock price, news, quote and history - Yahoo Finance Australia
Bio-Rad Laboratories, Inc. (BIO-B) Stock Price, News, Quote & History - Yahoo! Finance Canada
Bio-Rad Laboratories (HAM:BUWA) Net Intangibles Purchase An - GuruFocus
Q1 2026 Bio Rad Laboratories Inc Earnings Call Transcript - GuruFocus
RBC Capital reiterates Bio-Rad Labs stock rating on transformation outlook - Investing.com Nigeria
Bio Rad Laboratories Inc at Jefferies Global Healthcare Conference in New York Transcript - GuruFocus
Bio-Rad Laboratories Inc Stock Warning Signs - GuruFocus
Bio-Rad Laboratories Bets on Digital PCR, Margins and Smarter M&A Growth - Yahoo Finance
Bio-Rad Laboratories Inc. Class A (BIO) Key Financial Ratios – Valuation, Profitability & More - Value Research
BIO: Multi-year transformation leverages technology, M&A, and restructuring to drive growth and margin expansion - TradingView
BIO: Multi-year transformation leverages digital PCR leadership and targeted M&A for growth - TradingView
Bio-Rad at bernstein healthcare forum: shift toward profitable growth - Investing.com
Bio-Rad at bernstein healthcare forum: shift toward profitable growth By Investing.com - Investing.com Canada
Bio-Rad Laboratories, Inc. at Bernstein Insights Healthcare Leaders and Disruptors Transcript - GuruFocus
Biodesix Advances MRD Monitoring Programs With Bio-Rad and Thermo Fisher - Yahoo Finance
Biodesix advances MRD testing programs with Bio-Rad, Thermo Fisher - Investing.com
Biodesix advances MRD testing programs with Bio-Rad, Thermo Fisher By Investing.com - Investing.com India
Biodesix Announces Progress on Tumor-Informed and Tumor-Naïve MRD Programs with Bio-Rad and Thermo Fisher - Quiver Quantitative
Biodesix Advances Two Complementary Approaches to Molecular Residual Disease (MRD) Monitoring - The Manila Times
Here's Why You Should Hold Bio-Rad Stock in Your Portfolio for Now - Your Wyoming Link
Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating Challenges in the Medical Devices Sector - DirectorsTalk Interviews
Bio-rad Laboratories Stock Price Forecast. Should You Buy BIO? - StockInvest.us
Accelerating Legacy .NET Modernization at Bio-Rad with AWS Transform and Kiro - Amazon Web Services (AWS)
Bio-Rad to Participate in Fireside Chat During Bernstein Insights Healthcare Leaders and Disruptors 3rd Annual Forum - Investing News Network
Bio Rad (BIO) Stock Could Be 23% Overvalued As Column Expansion Continues - Yahoo Finance
Bio-Rad Laboratories, Inc. at Wells Fargo Healthcare Conference Transcript - GuruFocus
BIO-RAD LABORATORIES (NYSE: BIO) Grants 719 Derivative Securities to Director Allison Schwartz - Kalkine Media
BIO-RAD LABORATORIES Executive Evran Sedat Reports Exercising 3,880 Shares (NYSE: BIO) - Kalkine Media
Bio-Rad: Favorable Read-Across From Investor Event (NYSE:BIO) - Seeking Alpha
Bio-Rad (NYSE: BIO) director sees 320 RSUs convert, 116 shares withheld - Stock Titan
[Form 4] BIO-RAD LABORATORIES, INC. Insider Trading Activity - Stock Titan
Bio-Rad (NYSE: BIO) EVP logs 4,313 RSU grant and 2,179 vested shares - Stock Titan
1,453 stock units vest for Bio-Rad (NYSE: BIO) insider as 551 shares withheld - Stock Titan
Bio-Rad (NYSE: BIO) grants EVP 4,601 RSUs, with shares withheld at $386.11 - Stock Titan
Bio-Rad at Wells Fargo conference: margin push takes center stage - Investing.com Canada
Bio-Rad Terminates Forbes Tate Lobbying Pact - Legis1
Bio-Rad expands range of Foresight prepacked chromatography columns for biomanufacturing - selectscience.net
Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating Current Market Challenges with Strategic Insights - DirectorsTalk Interviews
Bio-Rad's Timing for Revenue Growth Recovery Remains Uncertain - Morningstar
BIO-RAD (NYSE: BIO) Director Allison Schwartz Reports 1,573 Shares Following Option Exercise - Kalkine Media
Mesa Laboratories Inc. (MLAB) Peer Comparison – Compare with Others - Value Research
RSU vesting gives Bio-Rad (NYSE: BIO) exec 425 shares - Stock Titan
Bio-Rad (BIO) Up 11.7% Since Last Earnings Report: Can It Continue? - finance.yahoo.com
Bio-Rad expands Foresight Pro prepacked chromatography columns with Nuvia ion exchange and mixed-mode resins - manufacturingchemist.com
Allied Healthcare Products Inc. (AHPI) Peer Comparison – Compare with Others - Value Research
Best Practices for qPCR Assay Design and Optimization - the-scientist.com
Bio Rad Laboratories Inc Azioni (BBIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.26%
0.38%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):